Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Delta-opioid agonists/antagonists described by SmithKline Beecham

April 29, 1997

Parke-Davis SAR studies lead to potent, selective D4 antagonist

April 28, 1997

Discovery of potent and selective mu-opiate receptor agonists

April 28, 1997

Mimetix initiates clinical trial with injectable form of naproxen

April 25, 1997

CoCensys discovers potent, water-soluble allosteric modulators of GABA-A receptor

April 25, 1997

Neurotrophic/neuroprotective agents described by Synthelabo

April 25, 1997

Clinical results from international comparative study of olanzapine and haloperidol

April 24, 1997

Eletriptan enters phase III trials

April 24, 1997

Yamasa describes cognition-enhancing agents

April 24, 1997

Arzneimittelwerk describes new anticonvulsants

April 24, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...